Initiation and regulation of antibacterial innate immunity

抗菌先天免疫的启动和调节

基本信息

  • 批准号:
    8891586
  • 负责人:
  • 金额:
    $ 45.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to explain how diverse innate immune response pathways can be activated by a single microbial product: bacterial lipopolysaccharide (LPS). While TLR4 is widely recognized to control transcriptional responses to LPS, TLR4-independent responses exist. Examples of such responses include endocytosis, activation of the transcription factor NFAT, and activation of non-canonical inflammasomes by caspase-11. The relationship between these diverse LPS responses is largely unknown, but as we will describe, at least some TLR4-independent responses control the classically-defined TLR4-dependent responses to LPS. Understanding how microbial products activate distinct signal transduction pathways may permit the design of drugs or vaccines that can target a subset of pathways therapeutically. Our proposal is founded on our recent discovery that LPS-induces the endocytosis of TLR4 by a process that does not require a functional TLR4 signaling (TIR) domain, or any of its associated adaptor proteins. Rather TLR4 is cargo for an endocytosis pathway that is activated by the LPS-binding protein CD14. While TLR4 does not direct its own endocytosis, this process is essential for TLR4 to induce TRIF-dependent signal transduction from endosomes. This discovery provides an example of how TLR4-dependent and -independent responses to LPS can be interdependent. In this grant application, we propose to 1) determine if a common signaling pathway is activated by CD14 to elicit diverse cell type-specific innate immune responses, 2) determine if common or distinct protein complexes exist that regulate diverse LPS inducible signaling pathways, and 3) identify the cell populations that directly respond to LPS produced by pathogenic bacterial infections in animal models of infection. Collectively, this work will provide important insight into the means by which diverse cellular responses to LPS are interconnected.
描述(由申请人提供):本提案的目的是解释单一微生物产物细菌脂多糖(LPS)如何激活多种先天免疫应答途径。虽然TLR 4被广泛认为控制对LPS的转录应答,但存在TLR 4非依赖性应答。这种反应的实例包括内吞作用、转录因子NFAT的活化和半胱天冬酶-11对非典型炎性体的活化。这些不同的LPS反应之间的关系在很大程度上是未知的,但正如我们将描述的,至少有一些TLR 4非依赖性反应控制经典定义的TLR 4依赖性反应的LPS。了解微生物产品如何激活不同的信号转导途径可能允许设计药物或疫苗,可以靶向治疗途径的子集。我们的建议是建立在我们最近的发现,LPS诱导TLR 4的内吞作用的过程中,不需要一个功能性TLR 4信号(TIR)结构域,或任何其相关的衔接蛋白。相反,TLR 4是内吞途径的货物,其被LPS结合蛋白CD 14激活。虽然TLR 4不指导其自身的内吞作用,但该过程对于TLR 4诱导来自内体的TRIF依赖性信号转导是必需的。这一发现提供了一个例子,如何TLR 4依赖性和非依赖性的反应,LPS可以是相互依赖的。在这项授权申请中,我们提出1)确定共同的信号传导途径是否被CD 14激活以引发不同细胞类型特异性先天免疫应答,2)确定是否存在共同或不同的蛋白质复合物来调节不同的LPS诱导的信号传导途径,以及3)鉴定在感染的动物模型中直接响应于由病原性细菌感染产生的LPS的细胞群。总的来说,这项工作将提供重要的洞察力的手段, 对LPS的不同细胞反应是相互关联的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN C KAGAN其他文献

JONATHAN C KAGAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN C KAGAN', 18)}}的其他基金

Regulation of immunity by the cGAS-STING pathway
cGAS-STING 通路对免疫的调节
  • 批准号:
    10583763
  • 财政年份:
    2022
  • 资助金额:
    $ 45.58万
  • 项目类别:
Regulation of immunity by the cGAS-STING pathway
cGAS-STING 通路对免疫的调节
  • 批准号:
    10707202
  • 财政年份:
    2022
  • 资助金额:
    $ 45.58万
  • 项目类别:
Characterization of the myddosome, a protein complex that controls TLR signaling
myddosome(一种控制 TLR 信号传导的蛋白质复合物)的表征
  • 批准号:
    9236656
  • 财政年份:
    2016
  • 资助金额:
    $ 45.58万
  • 项目类别:
Defining the pathways activated by Toll-like Receptors to stimulate immunity
定义 Toll 样受体激活的途径以刺激免疫力
  • 批准号:
    10209029
  • 财政年份:
    2016
  • 资助金额:
    $ 45.58万
  • 项目类别:
Defining the pathways activated by Toll-like Receptors to stimulate immunity
定义 Toll 样受体激活的途径以刺激免疫力
  • 批准号:
    10553667
  • 财政年份:
    2016
  • 资助金额:
    $ 45.58万
  • 项目类别:
Defining non-transcriptional innate immune responses to bacterial endotoxin
定义对细菌内毒素的非转录先天免疫反应
  • 批准号:
    8660126
  • 财政年份:
    2013
  • 资助金额:
    $ 45.58万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8434005
  • 财政年份:
    2011
  • 资助金额:
    $ 45.58万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8223165
  • 财政年份:
    2011
  • 资助金额:
    $ 45.58万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8824865
  • 财政年份:
    2011
  • 资助金额:
    $ 45.58万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8081944
  • 财政年份:
    2011
  • 资助金额:
    $ 45.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了